Edwards Lifesciences | EW - Profitto Lordo Sulle Vendite

Prezzo Delle Azioni
81.49
Cambio Giornaliero
-0.79 -0.96%
Mensile
2.50%
Annuale
7.95%
Q2 Previsione
82.35




Profitto Lordo Sulle Vendite Cambiamento Data
Abbott USD 5.86B 675M 2026-03
Artivion USD 73.14M 1.25M 2025-12
AtriCure USD 105.34M 4M 2025-12
Baxter International USD 577M 373M 2025-12
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Boston Scientific USD 3.61B 64M 2026-03
Cooper Companies USD 695.2M 44.4M 2025-12
Dexcom USD 792.7M 61.3M 2025-12
Edwards Lifesciences USD 1.29B 59.4M 2026-03
Globus Medical USD 535.95M 49.28M 2025-12
ICU Medical USD 202.98M 2.1M 2025-12
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
Intuitive Surgical USD 1.83B 73.8M 2026-03
J&J USD 17.24B 642M 2026-03
Masimo USD 247.3M 16.7M 2025-12
Medtronic USD 5.41B 27M 2025-12
Merit Medical Systems USD 195.35M 8.94M 2025-12
Stryker USD 4.49B 633M 2025-12
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12